Home https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ Health https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ If you hit COVID-19 but then develop this symptom weeks later, it can be fatal – BGR

If you hit COVID-19 but then develop this symptom weeks later, it can be fatal – BGR



  • A symptom that may appear benign may indicate that someone who has already taken COVID-19 is developing a frightening, potentially fatal coronavirus complication.
  • Adults are also at risk of developing the same multisystem inflammatory syndrome seen in children who survived COVID-19.
  • People who develop a skin rash a few weeks after clearing the COVID-19 infection may need immediate medical attention for a condition called MIS-A.

Coronavirus statistics include a misleading figure, one that will fool many people into thinking that COVID-19 is not as dangerous as people say. Out of nearly 40 million cases registered, about 1

.12 million people died from the disease. This means that everyone else either recovered (29.23 million people) or is currently fighting the disease (9.36 million). Many of these active cases will also recover in the coming weeks. What these numbers do not tell you is that many people who clear the virus will then experience unexpected and potentially serious complications. The phenomenon has come to be called “Long COVID”, a chronic version of the disease in which patients continue to exhibit various symptoms even after beating the virus. In addition, some people are at risk of developing a potentially life-threatening syndrome that was first seen in children who survived COVID-19. And it can all start with a symptom that you may not think is very serious.

Multisystem inflammatory syndrome in children (MIS-C) has now also been shown to affect adults, and the syndrome is called MIS-A. Both can be frightening, and both can lead to life-threatening complications that require hospitalization and even intensive care. These conditions can occur without warning after a coronavirus infection is cleared, but there are sometimes signs that a patient will experience MIS-C or MIS-A.

One of the first symptoms that COVID-19 survivors may see is a skin rash, NBC News reports. COVID-19 sometimes has unusual dermatological symptoms, including rashes and a phenomenon called Covid Toe. But this new rash would appear after COVID-19 is gone.

“Before I even saw the patient,” Dr. Alisa Femia NBC News, “I said, ‘This has not been reported yet. This must be MIS-A. The director of inpatient dermatology at NYU Langone Health in New York City looked at a patient’s chart that contained several photos. A 45-year-old man had cared for his wife in previous weeks while suffering from COVID-19. The man had “dark red, circular spots on the palms and soles of his feet” per NBC. He also had pink eyes and “extremely chapped” lips.

“The skin is right in front of your eyes,” Femia said. “You can not see it.”

Dermatologists may be more likely to observe this symptom in patients, but not everyone will associate it with MIS-C or MIS-A. However, these skin rashes appear to be an early indicator of this frightening post-COVID syndrome that some people experience. The condition can be underdiagnosed in adults because many doctors do not even look for it.

Aside from rashes, these patients could experience symptoms that may occur in COVID-19 as well as other conditions, including fever, chest pain, heart problems, and gastrointestinal problems. It is crucial that MIS-A patients do not show a key symptom of severe COVID-19, which is shortness of breath. Their COVID-19 PCR test would return negative results, while antibody tests may be positive, suggesting a recent improvement from the infection.

Doctors still cannot fully explain what causes inflammation inside the body after the new coronavirus is cleared, but MIS-C and MIS-A can both be fatal. Currently, there is no guaranteed cure for these inflammatory syndromes in COVID-19 survivors.

NBC reports that children are usually treated with intravenous immunoglobulin, an antibody treatment that has nothing to do with COVID-19 antibodies that plasma transfers would provide. Adults often receive steroids and interleukin-6 inhibitors, as they have already developed COVID-19 antibodies. Some doctors who spoke to NBC theorize that it is coronavirus antibodies that can cause MIS-A. But that is currently speculation, as there is no conclusive evidence that it supports it.

Chris Smith began writing about gadgets as a hobby, and before he knew it, he was sharing his views on technical stuff with readers around the world. Every time he does not write about gadgets, he miserably fails to stay away from them even though he is desperately trying. But that’s not necessarily a bad thing.




Source link